Scientists, entrepreneurs, and biotech executives will discuss their work developing next-generation neuroscience therapies and technologies in areas such as spinal-cord injuries, precision mental health, addiction, dementia, and Alzheimer’s.

Registration & Networking: 3 – 4 p.m.
Program: 4 – 5:30 p.m.
Reception: 5:30 – 6:30 p.m.

Recent relevant Xconomy coverage:

Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs?
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan

Agenda details coming soon…